100% of every donation goes directly to pancreatic cancer research.

Research Awards Listing

Research follows dollars, and The Lustgarten Foundation believes that increasing funds for pancreatic cancer research will translate into enhanced patient care, and ultimately, a cure.

The Lustgarten Foundation firmly believes that increasing funds for pancreatic cancer research is the surest path to improved patient care and eventually, to a cure. To date, we have committed nearly $120 million to providing the best and brightest minds with the resources to pursue the study and eradication of the disease.

View Award Listings by Year

2014  |  2013  |  2012  |  2011  |  2010  | 2009  |  2008  | 2007  |  2006  |  2005  |  2004  |  2003  |  2002  |  2001  |  2000-1998

2001 Research Grants

Columbia University
Argiris Efstratiadis, M.D., Ph.D.
Development of a Mouse Model of Pancreatic Cancer

Johns Hopkins Medical Institutions
Anirban Maitra, MBBS
Genetic Basis of Familial Pancreatic Cancer: A Novel Approach Using Whole Genome Conversion and High-Throughput Oligonucleotide Microarrays

Mayo Clinic at Rochester
Raul Urrutia, M.D.
Role of Novel Sp1-like Proteins in the Transcriptional Silencing Carcinogen-activating Enzymes in Exocrine Pancreatic Cells

Stanford University
Albert Koong, M.D., Ph.D.
Selective Modulators of Protein Kinase C Activity as a Novel Class of Hypoxia Cell Cytotoxins in Human Pancreatic Cancer

Stanford University
Anson W. Lowe, M.D.
Characterizing the Gene-expression Profile of Human Pancreatic Cancers

University of California at Davis Cancer Center
Richard Bold, M.D.
Anti-apoptotic Signaling through the AKT Kinase in Pancreatic Cancer

University of California at San Francisco Comprehensive Cancer Center
Martin McMahon, Ph.D.
A Systematic, Genome-Wide Analysis of Gene Copy Number Alteration in Pancreatic Cancer Cells by Array CGH

University of Michigan
Craig Logsdon, Ph.D.
The Role of ATDC in Radioresistance of Pancreatic Adenocarcinoma

University of Nebraska Medical Center/Eppley Cancer Research Institute
Michel Ouellette, Ph.D.
In-Vitro Models of Pancreatic Cancer Development

University of North Carolina at Chapel Hill
Adrienne D. Cox, Ph.D.
Functional Consequences of Oncogenically Mutated Kras in Pancreatic Cancer

University of Pittsburgh Cancer Institute
Katherine Pogue-Geile, Ph.D.
Functional Identification of Pancreatic Tumor Suppressor Genes

University of Pittsburgh Cancer Institute
Ramesh K. Ramanathan, M.D.
Co-Principal Investigator: Olivera Finn, Ph.D.
Phase I/II Study of a MUC-1 Pulsed Dendritic Cell Vaccine In Resected Pancreatic and Biliary Cancers

University of Texas M.D. Anderson Cancer Center
Lee Ellis, M.D.
Role of Neuropilin-1 in Pancreatic Cancer Growth and Angiogenesis

2015 website development and design sponsored by Celgene

1111 Stewart Avenue, Bethpage, New York 11714
Toll Free: 1-866-789-1000 P: 516-803-2304 F: 516-803-2303